Thomas Moran

Title: Thomas Moran: Innovator in Monoclonal Antibodies

Introduction

Thomas Moran is a distinguished inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has the potential to impact the treatment of viral infections.

Latest Patents

Moran's latest patents include groundbreaking advancements in the medical field. The first patent focuses on monoclonal antibodies against the JC virus. This patent provides monoclonal antibodies and antigen-binding fragments that specifically bind to the John Cunningham virus. It also details pharmaceutical compositions that include these antibodies, along with methods for their use in treating and preventing JCV infections and progressive multifocal leukoencephalopathy. The second patent relates to broadly neutralizing anti-human cytomegalovirus (HCMV) antibodies. This disclosure encompasses anti-HCMV antibodies and vaccines, as well as diagnostic and therapeutic methods for their application.

Career Highlights

Thomas Moran is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work is pivotal in advancing our understanding of viral infections and developing effective treatments.

Collaborations

Moran has collaborated with notable colleagues in his field, including Domenico Tortorella and Thomas Gardner. Their combined expertise contributes to the innovative research being conducted at the Icahn School of Medicine.

Conclusion

Thomas Moran's contributions to the field of monoclonal antibodies exemplify the importance of innovation in medical research. His patents hold promise for improving treatment options for viral infections, showcasing the impact of dedicated inventors in healthcare.